Citadel Advisors
RLM

Citadel Advisors’s Realm Therapeutics plc American Depositary Shares RLM Stock Holding History

Citadel Advisors’s Portfolio RLM Stock Details RLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,176
Closed -$46K – 10176
2019
Q2 		$46K Buy
+16,176
New +$53.4K ﹤0.01% 8752

Citadel Advisors's RLM Position: Q3 2019 in Review

Citadel Advisors sold out of Realm Therapeutics plc American Depositary Shares (RLM) in Q3 2019, closing a stake of 16,176 shares — an estimated $46K sold.

Citadel Advisors first reported a position in RLM in Q2 2019 and held it in 1 quarter. The position peaked at $46K in Q2 2019. 0 funds tracked by Wall St. Rank hold RLM as of Q3 2019.

  • Citadel Advisors reported no remaining Realm Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Citadel Advisors sold 16,176 Realm Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $46K.
  • Citadel Advisors first reported a position in Realm Therapeutics plc American Depositary Shares in Q2 2019 and held it in 1 quarter.
  • Citadel Advisors's Realm Therapeutics plc American Depositary Shares position peaked at $46K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Realm Therapeutics plc American Depositary Shares as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.